DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.
DAMAE Medical has raised $17.4M in total funding. The most recent round was Series B. The last funding was announced in November 2025.
DAMAE Medical's investors include ISPB, Partech, Kurma Partners, Idinvest Partners, EASME.
DAMAE Medical is headquartered in Paris, France.
DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.
DAMAE Medical is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DAMAE Medical — Funding & Investors." VCBacked, November 11, 2025, https://www.vcbacked.co/company/damae-medical. Accessed September 8, 2026.
VCBacked. (2025). DAMAE Medical — Funding & Investors. Retrieved September 8, 2026, from https://www.vcbacked.co/company/damae-medical
{{cite web |title=DAMAE Medical — Funding & Investors |url=https://www.vcbacked.co/company/damae-medical |website=VCBacked |access-date=September 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated